UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000037247
Receipt No. R000042445
Scientific Title Feasibility and efficacy of endoscopic laryngo-pharyngeal surgery(ELPS) and endoscopic submucosal dissection(ESD) for pharyngeal and laryngeal tumor
Date of disclosure of the study information 2019/07/03
Last modified on 2021/01/02 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Feasibility and efficacy of endoscopic laryngo-pharyngeal surgery(ELPS) and endoscopic submucosal dissection(ESD) for pharyngeal and laryngeal tumor
Acronym Feasibility and efficacy of endoscopic treatment for pharyngeal and laryngeal tumor
Scientific Title Feasibility and efficacy of endoscopic laryngo-pharyngeal surgery(ELPS) and endoscopic submucosal dissection(ESD) for pharyngeal and laryngeal tumor
Scientific Title:Acronym Feasibility and efficacy of endoscopic treatment for pharyngeal and laryngeal tumor
Region
Japan

Condition
Condition pharyngeal and laryngeal tumor
Classification by specialty
Gastroenterology Hepato-biliary-pancreatic medicine Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Treatment outcomes of ESD and ELPS for pharyngeal and laryngeal tumor
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Treatment outcomes of ESD and ELPS for pharyngeal and laryngeal tumor
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
99 years-old >=
Gender Male and Female
Key inclusion criteria 1) Patients with endoscopic submucosal dissection or endoscopic laryngo-pharyngeal surgery for pharyngeal or esophageal tumor.
2) Patients consent to be included in the study based on his/her own free will after sufficient informing and understanding of the study.
Key exclusion criteria 1) Cases having difficulty in endoscopic approach
2) Cases with Performance Status 4
3) Cases with sever complication in other organs except original disease
4) Cases judged by principal investigator to be inadequate as subjects
Target sample size 100

Research contact person
Name of lead principal investigator
1st name HAYATO
Middle name
Last name YAMAGUCHI
Organization Tokyo Medical University
Division name Department of Gastroenterology and Hepatology
Zip code 160-0023
Address 6-7-1 Nishishijuku, Shinjuku-ku, Tokyo
TEL 03-3342-6111
Email hayato10@tokyo-med.ac.jp

Public contact
Name of contact person
1st name HAYATO
Middle name
Last name YAMAGUCHI
Organization Tokyo Medical University
Division name Department of Gastroenterology and Hepatology
Zip code 160-0023
Address 6-7-1 Nishishijuku, Shinjuku-ku, Tokyo
TEL 03-3342-6111
Homepage URL
Email hayato10@tokyo-med.ac.jp

Sponsor
Institute Tokyo Medical University
Institute
Department

Funding Source
Organization Tokyo Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tokyo Medical University
Address 6-7-1 Nishishijuku, Shinjuku-ku, Tokyo
Tel 03-3342-6111
Email hayato10@tokyo-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 07 Month 03 Day
Date of IRB
2019 Year 06 Month 28 Day
Anticipated trial start date
2019 Year 07 Month 03 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Unpublished

Management information
Registered date
2019 Year 07 Month 03 Day
Last modified on
2021 Year 01 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042445